) Revenue Gross profit Selling Admin Net profit Q2/18 221,202 78,238 21,637 19,916 35,335 Q2/19 229,355 83,001 22,124 18,495 28,250 Change 8,153 4,763 487 (1,421) (7,085) % Change 3.7% 6.1% 2.3% (7.1%) (20.1

: Thousand Baht) Revenues Gross Profit Selling Admin Net(loss) profit Q2/17 222,225 80,232 19,957 22,698 (293,091)*** Q2/18 221,202 78,238 21,637 19,916 35,335 Change -1,023 -1,994 1,680 -2,782 328,426

of 2019. A summary of the Company’s operating performance in the first quarter of 2020 and 2019 is shown in the following table: 1Q20 4Q19 % Change 1Q19 % Change [Amount in Baht Million] Q-o-Q Y-o-Y

., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 080/63 August 7, 2020 Subject: Clarification of the Operating Result for the significant change Attention: The

Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 As of March 31, 2020

10.73% 30 September 2020 31 December 2019 Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin

difference in the procedures to the extent that it will not materially change the work system and personnel provided in the application; (2) the rules and regulations of the derivatives exchange necessary for

. - Biological assets – dairy cow increased for Baht 0.16 million, because gain from change in fair less estimated point-of-sale cost dairy cow - Other assets were cash and equivalent transactions to cash

226.28 (24.55) 226.22 (24.62) Shares of gain (loss) from investments in an associate and a joint venture 2.83 25.08 0.00 0.00 Gain from change in a joint venture proportion 0.00 (9.87) 0.00 0.00 Gain on

million in 2017 which did not reoccur in 2018. The decline in gain on sales of investment was partially offset by an increase in gain on change in fair value of investment property amounting to Baht 45